A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

NCT05259722 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hand Eczema

Interventions

DRUG: Delgocitinib
DRUG: Toctino

Sponsor

LEO Pharma